Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2003
12/04/2003US20030225064 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003CA2486564A1 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367111A1 Photochromic material
12/03/2003EP1367049A1 Cyanothioacetamide derivative and process for producing the same
12/03/2003EP1283838B1 Piperazine and piperidine compounds
12/03/2003EP1161417B1 Methods and compositions for treating leukemia
12/03/2003EP1119557B1 Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129588C Process for preparing 5-methyl-2-thiazoamine
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
11/2003
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097621A1 Methods of using thiazolidinedithione derivatives
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097060A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives
11/27/2003WO2003097048A1 Diaminothiazoles
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003080828A3 Nucleic acid molecules involved in the synthesis of melithiazols
11/27/2003WO2003037338A3 Modulators of the cholesterol biosynthetic pathway
11/27/2003WO2003015717A3 Tyrosine kinase inhibitors
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220503 Hydroxylation, carboxylation, cyclization, esterification, epoxidation, etherification
11/27/2003US20030220380 Administering to a mammal an aminothiazole derivative to treat thrombosis, myocardial infarction, pulmonary infarction, intra- atrial thrombus in atrial fibrillation, deep venous thrombus, and restenosis or stroke
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220326 Compounds, pharmaceutical compositions, and methods for inhibiting cyclin-dependent kinases
11/27/2003US20030220295 Epothilone derivatives
11/27/2003US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors
11/27/2003CA2486138A1 Methods of using thiazolidinedithione derivatives
11/27/2003CA2485869A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives
11/27/2003CA2485367A1 Diaminothiazoles
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/26/2003EP1364040A2 Degradation of epothilones and ethynyl substituted epothilones
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003CN1458143A Process for preparing N-aroyl-L-glutaminic acid
11/26/2003CN1128803C Epothilones B-N-oxidant and its preparing method
11/25/2003USRE38330 Preventing and reversing advanced glycosylation endproducts
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653340 2-amidino-5 or 6-benzofuranyl or benzothiophenyl 2-furanyl, thiophenyl or benzyl carboxylates; serine protease inhibitors potent against Factor D of the alternate complement pathway
11/25/2003US6653331 Targeted drug delivery using sulfonamide derivatives
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003CA2163028C New thiazolidinediones and pharmaceutical agents containing them
11/25/2003CA2140246C Herbicidal agents based on heterocyclic aryloxyacetamides
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095435A1 Amide derivatives
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003050062A3 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216579 Reactin a thiazole compound with glycidyl aldehyde
11/20/2003US20030216454 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/20/2003US20030216453 Thiazolidine derivatives and its use as antifungal agent
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216442 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216432 Non-insulin sensitive diabetes; anticancer agents ; therapy, medical diagnosis
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030215667 Electroluminescent devices
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP1362037A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0870765B1 Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds
11/19/2003EP0801687B1 Electrochemiluminescence assay
11/18/2003US6649767 Contacting an enamine compound with a ketonic compound in presence of a base, treating the reaction mixture thus obtained with an acid or combinations of acids
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649635 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
11/18/2003US6649335 Cyanine dye
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092683A1 Epothilone derivative for the treatment of hepatoma and other cancer diseases
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092374A2 Pesticidal heterocycles
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 337